Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumor (PRIME)
Phase Ib/II Multicohort Trial of Different Schemes of PM14 in Monotherapy and in Combination with Radiotherapy in Soft Tissue Sarcomas and Other Solid Tumors
Sponsor: Grupo Espanol de Investigacion en Sarcomas
This PHASE1/PHASE2 trial investigates Advanced L-sarcomas and Advanced Soft-tissue Sarcoma and is currently actively recruiting participants. Grupo Espanol de Investigacion en Sarcomas leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE1/PHASE2
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2022 — Feb 2024 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2022 — Sep 2022 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Nov 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Grupo Espanol de Investigacion en Sarcomas
For direct contact, visit the study record on ClinicalTrials.gov .